Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street

Show Stocks and Investing Publications

Fri, December 6, 2024

[ Fri, Dec 06th 2024 ]: The Motley Fool Canada

Build a Cash-Gushing Passive-Income Portfolio With Just $40,000

[ Fri, Dec 06th 2024 ]: 24/7 Wall St

Microsoft (MSFT) Price Prediction and Forecast 2025-2030

[ Fri, Dec 06th 2024 ]: thenightly

BlackRock unveils 2025 predictions, says artifici .. ntelligence will eliminate 'boom and bust' cycles

[ Fri, Dec 06th 2024 ]: ABC

Stock market today: Wall Street rises after solid jobs data keeps hope alive for a coming rate cut

[ Fri, Dec 06th 2024 ]: USA Today

Wall Street stocks, Bitcoin take breath from record highs ahead of US jobs data

[ Fri, Dec 06th 2024 ]: Forbes

3 Long-Term Stocks To Buy In 2025

[ Fri, Dec 06th 2024 ]: The Motley Fool Canada

TSX on the Rise: 4 Momentum Stocks to Buy Immediately

[ Fri, Dec 06th 2024 ]: Forbes

Johnson & Johnson Enters Oversold Territory

[ Fri, Dec 06th 2024 ]: 24/7 Wall St

SoFi Technologies (SOFI) Price Prediction and Forecast 2025-2030

[ Fri, Dec 06th 2024 ]: Business Insider

Oriental Rise Holdings Ltd trading resumes

[ Fri, Dec 06th 2024 ]: FXStreet

Gold Price Forecast: XAU/USD's path of least resi .. ce appears down as US Nonfarm Payrolls data looms

[ Fri, Dec 06th 2024 ]: Kiplinger

Ulta Beauty Stock Gets a Much-Needed Boost After Earnings

[ Fri, Dec 06th 2024 ]: 24/7 Wall St

Should I buy a stock before or after a stock split?

[ Fri, Dec 06th 2024 ]: The Globe and Mail

Athabasca Oil Announces 2025 Budget Focused on Ca .. ing 100% of Free Cash Flow to Shareholder Returns

[ Fri, Dec 06th 2024 ]: Business Insider

Stock market today: Indexes rise as rate-cut odds edge up after jobs report

[ Fri, Dec 06th 2024 ]: bnnbloomberg

BlackRock's Big Bet on GIP Puts Fink's Firm in Local Spotlight

[ Fri, Dec 06th 2024 ]: bnnbloomberg

A $500 Billion Haul Reignites Passive Controversy on Wall Street

[ Fri, Dec 06th 2024 ]: The Globe and Mail

3 Reasons Why I Bought Celsius Stock

[ Fri, Dec 06th 2024 ]: FTAdviser

What Trump's win means for investors

[ Fri, Dec 06th 2024 ]: The Globe and Mail

ERES Files Management Information Circular for Sp .. es Unitholders to Access Meeting Materials Online

[ Fri, Dec 06th 2024 ]: Morningstar

5 Essential Investment Lessons From 2024

[ Fri, Dec 06th 2024 ]: FXStreet

Dow Jones Industrial Average backslides as NFP Friday looms

[ Fri, Dec 06th 2024 ]: The Daily Telegraph

Bitcoin soars to record high - should you invest in it?

[ Fri, Dec 06th 2024 ]: MSN

Bitcoin in Your Retirement Account? A Little Wouldn't Hurt.

[ Fri, Dec 06th 2024 ]: MSN

Personal Loan: Should you use it for investment? Pros and cons revealed

[ Fri, Dec 06th 2024 ]: Sky

Money blog: We don't want this 'thoughtful' alter .. ive to cash as Christmas present, Britons declare

[ Fri, Dec 06th 2024 ]: Zawya

XTB harnesses its bet on AI-Tech

[ Fri, Dec 06th 2024 ]: Morningstar

News Highlights: Top Company News of the Day - Friday at 1 AM ET

[ Fri, Dec 06th 2024 ]: Business Standard

Stock Market LIVE Updates: GIFT Nifty signals sli .. t gains at open as markets await RBI MPC decision

[ Fri, Dec 06th 2024 ]: The Motley Fool

Why Archer Aviation Stock Is Soaring Today

[ Fri, Dec 06th 2024 ]: MSN

Guess which top 100 ASX stock this $139 billion superannuation fund ditched

[ Fri, Dec 06th 2024 ]: 24/7 Wall St

Amazon Stock (AMZN) Price Prediction and Forecast 2025-2030

[ Fri, Dec 06th 2024 ]: Motley Fool Australia

Own ANZ shares? Here's the outlook for 2025

[ Fri, Dec 06th 2024 ]: The Globe and Mail

Why Jumia Stock Skyrocketed Today

[ Fri, Dec 06th 2024 ]: The Motley Fool

Target vs. Walmart: What's the Better Dividend Stock to Buy and Hold?

[ Fri, Dec 06th 2024 ]: MSN

SEBI proposes new mechanism to determine stock closing price

[ Fri, Dec 06th 2024 ]: The Motley Fool

Nvidia Stock vs. Apple Stock: Billionaires Are Buying One and Selling the Other

[ Fri, Dec 06th 2024 ]: The Motley Fool

3 of the Best Growth Stocks You Can Buy for Less than $100

Thu, December 5, 2024

[ Thu, Dec 05th 2024 ]: The Motley Fool

Why Intel Stock Was Sliding Again Today

[ Thu, Dec 05th 2024 ]: marketindex

Big brokers warn of "generational" overvaluations in ANZ, Commonwealth Bank, NAB and Westpac

[ Thu, Dec 05th 2024 ]: The Motley Fool UK

Starting a Stocks and Shares ISA in 2025 could make me a millionaire. Here's how!

[ Thu, Dec 05th 2024 ]: The Globe and Mail

Stock Market Crash 2025: Economists Warn of an Im .. k Market Crash: Are Equities Overinflated by 80%?

[ Thu, Dec 05th 2024 ]: The Motley Fool

Why Is Everyone Talking About AppLovin Stock?

[ Thu, Dec 05th 2024 ]: Yahoo Finance

Here's Why Shopify (SHOP) is a Strong Momentum Stock

[ Thu, Dec 05th 2024 ]: AOL

Avoid these 4 common bond buying mistakes

[ Thu, Dec 05th 2024 ]: MSN

1 Dividend Growth Star Perfect for a TFSA

[ Thu, Dec 05th 2024 ]: MSN

What Pilgrim's Pride Investors Should Watch Heading Into 2025

[ Thu, Dec 05th 2024 ]: MSN

Will 2025 be a good year for the BHP share price?

Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street

//stocks-investing.news-articles.net/content/202 .. uld-soar-nearly-20-according-to-wall-street.html

Published in Stocks and Investing on Friday, December 6th 2024 at 6:01 GMT by The Motley Fool
^{🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source}

However, Englander's interest isn't limited to tech stocks. The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall Street.

The article from The Motley Fool discusses billionaire investor Izzy Englander's recent investment in the obesity treatment sector. Englander, through his hedge fund Millennium Management, has been acquiring shares in companies like Eli Lilly and Novo Nordisk, which are at the forefront of developing and marketing weight-loss drugs such as Mounjaro and Wegovy. These drugs have shown significant promise in treating obesity, a condition affecting millions globally, and are expected to generate substantial revenue due to high demand. The article highlights the potential of these treatments to revolutionize obesity management, potentially leading to a multi-billion dollar market. Englander's investment reflects a broader trend among investors betting on the future of obesity treatments, driven by the drugs' efficacy and the growing prevalence of obesity-related health issues.

Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2024/12/06/billionaire-izzy-englander-buying-obesity-stock/ ]